A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine

Clinical trial NCT05680454 · COMPLETED

Trial details

NCT number: NCT05680454
Sponsor: Beijing Health Guard Biotechnology, Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Human Papillomavirus Infection

Start date: 2019-09-01
Primary completion: 2020-04-06
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.